A decreasing trend of FT3 with increasing COVID-19 severity was found, and patients with low FT3 had more adverse COVID-19-related outcomes.
← all excerpts
The Potential of Thyroid Hormone Therapy in Severe COVID-19: Rationale and Preliminary Evidence.
1
—
—